Denali Therapeutics shares owned by Guggenheim Capital, LLC Managers
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Guggenheim Capital, LLC Managers
from 13F filings
Historical chart of Guggenheim Capital, LLC Managers investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Guggenheim Capital, LLC Managers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Guggenheim Capital, LLC Managers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $373k | 17k | 21.46 |
| 2023-09-30 | $1.2M | 57k | 20.63 |
| 2023-06-30 | $1.6M | 54k | 29.51 |
| 2023-03-31 | $1.3M | 56k | 23.04 |
| 2022-12-31 | $1.8M | 65k | 27.81 |
| 2022-09-30 | $1.6M | 50k | 31.07 |
| 2022-06-30 | $1.8M | 61k | 29.18 |
| 2022-03-31 | $1.7M | 54k | 31.82 |
| 2021-12-31 | $2.1M | 47k | 44.59 |
More positions owned by Guggenheim Capital, LLC Managers
View all positions for Guggenheim Capital, LLC Managers